| Study Of Asthma In Patients Of African Descent (NCT00102765) | GlaxoSmithKline | 2004-11-01 |
| Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS (NCT00316732) | GlaxoSmithKline | 2004-10-25 |
| Ispinesib In Combination With Carboplatin In Patients With Solid Tumors (NCT00136578) | GlaxoSmithKline | 2004-10-20 |
| Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18 (NCT00196937) | GlaxoSmithKline | 2004-10-07 |
| A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors (NCT00259935) | GlaxoSmithKline | 2004-10-04 |
| A Study To Investigate Markers Of Inflammation In Rheumatoid Arthritis (NCT00242853) | GlaxoSmithKline | 2004-10-01 |
| Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures (NCT00113165) | GlaxoSmithKline | 2004-10-01 |
| Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate (NCT00102882) | GlaxoSmithKline | 2004-10-01 |
| Nine-Weeks Treatment With 683699 In Subjects With Moderately-To-Severely Active Crohn's Disease (NCT00101946) | GlaxoSmithKline | 2004-10-01 |
| Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina (NCT01387165) | GlaxoSmithKline | 2004-10-01 |
| Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at Birth (NCT00317122) | GlaxoSmithKline | 2004-10-01 |
| ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies. (NCT00144911) | GlaxoSmithKline | 2004-10-01 |
| Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS) (NCT00101985) | GlaxoSmithKline | 2004-10-01 |
| Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma (NCT00268983) | GlaxoSmithKline | 2004-10-01 |
| HuMax-CD20 in Chronic Lymphocytic Leukemia (NCT00093314) | GlaxoSmithKline | 2004-10-01 |
| Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes (NCT00367055) | GlaxoSmithKline | 2004-10-01 |
| A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine (NCT00169481) | GlaxoSmithKline | 2004-10-01 |
| Study Of GW679769 In Major Depressive Disorder (NCT00102492) | GlaxoSmithKline | 2004-10-01 |
| A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting (NCT00108095) | GlaxoSmithKline | 2004-10-01 |
| Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome (NCT00097370) | GlaxoSmithKline | 2004-09-30 |
| Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients (NCT00158782) | GlaxoSmithKline | 2004-09-28 |
| GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults (NCT00089986) | GlaxoSmithKline | 2004-09-01 |
| A Study to Assess the Effect of SB 659032 on Platelet Function (NCT01750827) | GlaxoSmithKline | 2004-09-01 |
| Sexual Functioning Study With Antidepressants (NCT00316160) | GlaxoSmithKline | 2004-09-01 |
| Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 (NCT00169494) | GlaxoSmithKline | 2004-09-01 |
| Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma (NCT00092274) | GlaxoSmithKline | 2004-09-01 |
| Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children (NCT00144846) | GlaxoSmithKline | 2004-09-01 |
| In-Patient Study In Schizophrenic Patients (NCT00197093) | GlaxoSmithKline | 2004-09-01 |
| A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus (NCT01571661) | GlaxoSmithKline | 2004-09-01 |
| Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma (NCT00354666) | GlaxoSmithKline | 2004-09-01 |
| Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects (NCT00158873) | GlaxoSmithKline | 2004-09-01 |
| To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines (NCT00140686) | GlaxoSmithKline | 2004-09-01 |
| Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis (NCT00097331) | GlaxoSmithKline | 2004-09-01 |
| Rollover Study Of Lapatinib In Cancer Patients (NCT00169533) | GlaxoSmithKline | 2004-08-19 |
| Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine (NCT00129129) | GlaxoSmithKline | 2004-08-01 |
| GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol (NCT00158899) | GlaxoSmithKline | 2004-08-01 |
| HEPSERA Post Marketing Surveillance (NCT01329419) | GlaxoSmithKline | 2004-08-01 |
| Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects (NCT00354042) | GlaxoSmithKline | 2004-08-01 |
| Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose. (NCT00317161) | GlaxoSmithKline | 2004-08-01 |
| A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia (NCT00650871) | GlaxoSmithKline | 2004-07-30 |
| Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine (NCT00289796) | GlaxoSmithKline | 2004-07-01 |
| Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine (NCT00406211) | GlaxoSmithKline | 2004-07-01 |
| A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study) (NCT00094367) | GlaxoSmithKline | 2004-07-01 |
| Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults. (NCT00291889) | GlaxoSmithKline | 2004-07-01 |
| Study Of Ispinesib In Subjects With Breast Cancer (NCT00089973) | GlaxoSmithKline | 2004-06-30 |
| GW572016 In Patients With Advanced Or Metastatic Breast Cancer (NCT00462956) | GlaxoSmithKline | 2004-06-30 |
| Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants (NCT00128661) | GlaxoSmithKline | 2004-06-30 |
| Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer (NCT00359190) | GlaxoSmithKline | 2004-06-29 |
| A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. (NCT00158860) | GlaxoSmithKline | 2004-06-21 |
| Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. (NCT00317187) | GlaxoSmithKline | 2004-06-08 |
| Human Papilloma Virus Vaccine Safety and Immunogenicity Trial in Young Adolescent Women With GSK Bio HPV-16/18. (NCT00196924) | GlaxoSmithKline | 2004-06-01 |
| Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT00662805) | GlaxoSmithKline | 2004-06-01 |
| Effects Of Oral Prednisolone On Bone Metabolism In Patients With Chronic Obstructive Pulmonary Disease (NCT00384306) | GlaxoSmithKline | 2004-06-01 |
| Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer (NCT00089999) | GlaxoSmithKline | 2004-06-01 |
| Major Depressive Disorder In The Elderly (NCT00093288) | GlaxoSmithKline | 2004-06-01 |
| SB-715992 In Combination With Docetaxel In Patients With Solid Tumors (NCT00169520) | GlaxoSmithKline | 2004-06-01 |
| An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010 (NCT01294553) | GlaxoSmithKline | 2004-06-01 |
| Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease (NCT00265148) | GlaxoSmithKline | 2004-05-18 |
| Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 (NCT00122681) | GlaxoSmithKline | 2004-05-06 |
| Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years (NCT00197119) | GlaxoSmithKline | 2004-05-01 |
| Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants (NCT00290303) | GlaxoSmithKline | 2004-05-01 |
| ARIXTRA Local Study For Registration In China. (NCT00328939) | GlaxoSmithKline | 2004-05-01 |
| KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks (NCT00085943) | GlaxoSmithKline | 2004-05-01 |
| Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT (NCT01476059) | GlaxoSmithKline | 2004-05-01 |
| Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia (NCT00086593) | GlaxoSmithKline | 2004-05-01 |
| Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies. (NCT00355342) | GlaxoSmithKline | 2004-04-28 |
| A Study Comparing The Safety, Tolerability and Efficacy of Trizivir VS Combivir & Atazanavir In Subjects With HIV (NCT00082394) | GlaxoSmithKline | 2004-04-26 |
| Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs (NCT00343915) | GlaxoSmithKline | 2004-04-21 |
| Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old (NCT00224484) | GlaxoSmithKline | 2004-04-07 |
| Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas (NCT00085904) | GlaxoSmithKline | 2004-04-01 |
| Tositumomab And Iodine I 131-Tositumomab In Patients With Relapsed Indolent Non-Hodgkin's Lymphoma (NCT00240565) | GlaxoSmithKline | 2004-04-01 |
| Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-Experienced HIV1 Infected Adults (NCT00090077) | GlaxoSmithKline | 2004-04-01 |
| SB-743921 In Patients With Solid Tumors (NCT00136513) | GlaxoSmithKline | 2004-04-01 |
| Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) (NCT00086658) | GlaxoSmithKline | 2004-03-23 |
| A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique. (NCT00197067) | GlaxoSmithKline | 2004-03-15 |
| A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons (NCT00079911) | GlaxoSmithKline | 2004-03-12 |
| Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer (NCT00078572) | GlaxoSmithKline | 2004-03-01 |
| Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects (NCT00648284) | GlaxoSmithKline | 2004-03-01 |
| Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule (NCT00289744) | GlaxoSmithKline | 2004-02-16 |
| AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes (NCT00359112) | GlaxoSmithKline | 2004-02-01 |
| An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease (NCT00632736) | GlaxoSmithKline | 2004-02-01 |
| Effects Of Prednisolone On Rheumatoid Arthritis Patients (NCT00330889) | GlaxoSmithKline | 2004-02-01 |
| Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population (NCT00307528) | GlaxoSmithKline | 2004-01-20 |
| Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS) (NCT00480649) | GlaxoSmithKline | 2004-01-01 |
| Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer (NCT00075270) | GlaxoSmithKline | 2004-01-01 |
| Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule (NCT00291876) | GlaxoSmithKline | 2004-01-01 |
| Special Drug Use Investigation for PAXIL Tablet (20mg-Clinical Symptom Progression) (NCT01371461) | GlaxoSmithKline | 2004-01-01 |
| Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule (NCT00289757) | GlaxoSmithKline | 2004-01-01 |
| Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol (NCT00327353) | GlaxoSmithKline | 2004-01-01 |
| Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults (NCT00730795) | GlaxoSmithKline | 2004-01-01 |
| A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise (NCT00118716) | GlaxoSmithKline | 2003-12-23 |
| Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. (NCT00317135) | GlaxoSmithKline | 2003-12-11 |
| Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine (NCT00325143) | GlaxoSmithKline | 2003-12-01 |
| Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine (NCT00224471) | GlaxoSmithKline | 2003-12-01 |
| A Study to Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants (NCT00197210) | GlaxoSmithKline | 2003-12-01 |
| Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer (NCT00085813) | GlaxoSmithKline | 2003-12-01 |
| Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's (NCT00363727) | GlaxoSmithKline | 2003-12-01 |
| Study of 2 Doses of HRV Vaccine Given Concomitantly With Routine EPI Vaccinations Including OPV in Healthy Infants (NCT00139347) | GlaxoSmithKline | 2003-12-01 |
| A Study Measuring Asthma Control In Pediatric And Adolescent Subjects Whose Asthma Is Worsened By Activity Or Exercise (NCT00118690) | GlaxoSmithKline | 2003-12-01 |
| Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus (NCT01045590) | GlaxoSmithKline | 2003-12-01 |